Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Immunity|April 23, 2013
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerJan C Dudda, Bruno Salaun, Yun Ji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
T-cell receptor gene therapy of established tumors in a murine melanoma modelJohn D Abad, Claudia Wrzensinski, Willem Overwijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
Pageof 7